249420 — Il Dong Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Market Cap
KR₩725bn
Enterprise Value
KR₩803bn
Revenue
KR₩567bn

Annual balance sheet for Il Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	154,681	78,746	62,758	74,872	64,845
Net Total Accounts Receivable
Net Total Receivables	55,145	58,326	62,975	68,559	52,209
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	301,550	282,035	235,681	246,991	221,965
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	247,790	255,317	256,380	221,443	220,696
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	708,970	655,810	611,261	589,043	573,031
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	364,141	316,290	314,230	275,967	230,969
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	556,062	464,567	441,718	428,285	326,609
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	152,909	191,244	169,543	160,758	246,422
Total Liabilities & Shareholders' Equity	708,970	655,810	611,261	589,043	573,031
Total Common Shares Outstanding